Ziccum CEO Ann Gidner’s presentation at RNA Leaders in San Diego on September 4th, 2024, drew significant attention from key stakeholders in the RNA development community. It addressed a critical challenge in the mRNA field: how to create high-yield, particle engineered, thermostable, and robust drug forms to unlock the full potential of mRNA.
CEO Ann Gidner: “We had a well-placed speaker slot and got good attention, with new dialogues regarding interesting applications. It’s always rewarding to reconnect with key contacts and meet new, promising collaborators as we strive to contribute to the next era of RNA innovation. Thank you to everyone who made this event a success.”
Scientific Director Fabrice Rose: “It was a valuable experience to attend this event and stay updated on the latest developments in the rapidly evolving RNA field. I am pleased with the strong interest in our technology and our latest mRNA findings with LaminarPace.”